CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
301277 Newland Pharmaceutical
- 11.45
- -0.36-3.05%
Market Closed Apr 30 15:00 CST
4.49BMarket Cap25.73P/E (TTM)
11.93High11.45Low153.23KlotVolume11.78Open11.81Pre Close178.46MTurnover15.17%Turnover Ratio25.85P/E (Static)392.08MShares14.2352wk High3.02P/B1.16BFloat Cap7.9952wk Low14.17Limit Up101.02MShs Float17.03Historical High9.45Limit Down4.06%Amplitude6.15Historical Low0.29Dividend TTM11.65Avg Price89.79KlotAsk2.50%Div YieldTTM100Lot Size61.79KlotBid
Newland Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 39.02%334.4M | 4.28%281.58M | 24.28%322.75M | 28.60%295.41M | 25.69%240.53M | 428.07%270.02M | 626.83%259.7M | 674.96%229.71M | --191.38M | 49.46%51.13M |
| Transactional financial assets | -26.92%453.13M | -10.91%525.16M | -9.31%481.04M | -10.18%504.07M | 6.74%620.07M | -15.95%589.5M | 10,488.60%530.4M | 9,141.65%561.23M | --580.93M | 7,993.06%701.36M |
| Notes receivable and accounts receivable | -4.95%229.14M | 48.06%263.53M | 0.35%230.81M | 16.68%293.48M | -21.71%241.07M | -33.25%177.99M | 8.00%230.01M | -15.36%251.51M | --307.91M | 17.31%266.65M |
| -Notes receivable | -46.81%64.11M | 65.14%113.93M | 21.85%129.7M | 5.26%140.93M | -38.30%120.53M | -21.16%68.99M | 68.03%106.45M | 71.37%133.89M | --195.36M | 14.84%87.51M |
| -Accounts receivable | 36.91%165.03M | 37.25%149.6M | -18.18%101.1M | 29.68%152.54M | 7.10%120.54M | -39.16%109M | -17.42%123.56M | -46.29%117.63M | --112.55M | 18.55%179.15M |
| Other receivables (including interest and dividends) | 210.95%607.04K | 25.06%237.2K | -19.61%203.74K | -62.11%109.73K | -57.41%195.22K | -26.30%189.67K | 81.47%253.44K | 238.35%289.58K | --458.35K | 61.38%257.36K |
| -Other receivable | ---- | ---- | ---- | -62.11%109.73K | ---- | -26.30%189.67K | ---- | 238.35%289.58K | ---- | 61.38%257.36K |
| Advance payment | -71.10%2.59M | -86.59%2.63M | -64.64%3.11M | -27.82%2.7M | 187.65%8.96M | 732.44%19.65M | 158.46%8.81M | 67.39%3.74M | --3.12M | 81.73%2.36M |
| Inventories | -8.98%31.35M | 45.34%45.06M | 40.33%38.57M | 34.62%30.98M | -1.57%34.44M | -42.07%31M | -56.60%27.48M | -46.52%23.01M | --34.99M | -31.88%53.52M |
| Receivable financing | 5.07%95.66M | 9.82%69.09M | -34.58%89.21M | -28.99%74.08M | -23.62%91.04M | -32.93%62.91M | -14.36%136.37M | 18.36%104.33M | --119.19M | 121.85%93.8M |
| Other current assets | 16.30%7.54M | 43.30%7.73M | -8.04%4.44M | 326.93%5.72M | -52.52%6.48M | -70.07%5.39M | -66.97%4.82M | -87.81%1.34M | --13.65M | 112.08%18.02M |
| Total current assets | -7.11%1.15B | 3.32%1.2B | -2.31%1.17B | 2.67%1.21B | -0.71%1.24B | -2.57%1.16B | 142.26%1.2B | 146.19%1.18B | --1.25B | 196.03%1.19B |
| Non Current assets | ||||||||||
| Fixed assets | ---- | ---- | ---- | 15.72%289.63M | ---- | 18.72%278.49M | ---- | 25.15%250.29M | ---- | 21.77%234.58M |
| Constru in process | ---- | ---- | ---- | 154.82%189.39M | ---- | 92.78%106.7M | ---- | 182.47%74.32M | ---- | 67.64%55.35M |
| Intangible assets | -3.35%36.5M | -3.32%36.82M | -3.39%37.13M | -2.55%37.45M | -1.88%37.77M | -1.78%38.08M | -1.42%38.44M | -2.13%38.43M | --38.49M | -2.35%38.77M |
| Long deferred expense | -44.10%2.83M | -39.72%3.38M | -34.75%3.94M | -31.66%4.5M | 331.38%5.06M | 334.03%5.61M | 327.03%6.04M | --6.58M | --1.17M | --1.29M |
| Usufruct assets | 186.83%7.67M | 6.89%3.22M | -59.87%1.46M | -56.54%2.06M | -45.77%2.68M | -46.06%3.01M | -25.79%3.65M | -12.73%4.75M | --4.93M | --5.59M |
| Other non current assets | 170.25%37.01M | -82.21%3.73M | 16.06%5.24M | -14.92%8.08M | 15.11%13.69M | 89.15%20.96M | -79.77%4.52M | -30.15%9.5M | --11.9M | 2,074.13%11.08M |
| Total non current assets | 43.44%692.49M | 36.62%618.71M | 44.39%570.19M | 38.36%531.11M | 34.41%482.77M | 30.63%452.86M | 31.67%394.89M | 34.80%383.87M | --359.17M | 29.89%346.66M |
| Total assets | 7.03%1.85B | 12.69%1.81B | 9.27%1.74B | 11.46%1.74B | 7.13%1.73B | 4.94%1.61B | 100.51%1.59B | 104.57%1.56B | 113.10%1.61B | 129.64%1.53B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --855.93K | --729.97K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | -19.55%100.43M | 58.01%138.66M | 22.08%130.72M | 36.24%152.64M | -8.55%124.83M | -17.50%87.75M | 4.54%107.08M | 12.37%112.04M | --136.51M | 32.54%106.37M |
| -Notes payable | --851.81K | --851.81K | ---- | ---- | ---- | ---- | ---- | ---- | --2.99M | 119.46%11.31M |
| -Accounts payable | -20.23%99.58M | 57.04%137.81M | 22.08%130.72M | 36.24%152.64M | -6.51%124.83M | -7.69%87.75M | 13.23%107.08M | 33.59%112.04M | --133.52M | 26.58%95.07M |
| Contract liabilities | -55.72%2.05M | 20.08%5.32M | -77.26%1.27M | -44.58%1.51M | -15.79%4.64M | -3.92%4.43M | -26.55%5.6M | -51.91%2.73M | --5.5M | 174.46%4.61M |
| Salaries payable | 0.84%14.51M | 14.57%19.79M | 7.88%15.2M | 24.91%16.16M | 23.33%14.39M | 22.06%17.27M | 3.90%14.09M | 22.58%12.93M | --11.66M | 10.05%14.15M |
| Taxs payable | 158.64%8.12M | -14.65%1.21M | -70.57%1.66M | -1.94%4.72M | -68.44%3.14M | 56.99%1.42M | 65.41%5.65M | -24.29%4.82M | --9.94M | -93.13%903.6K |
| Other payable (including interest and dividends) | 131.77%59.73M | 93.56%50.38M | 86.98%32.98M | 49.91%35.27M | 22.49%25.77M | -1.91%26.03M | 25.86%17.64M | 70.14%23.53M | --21.04M | 61.49%26.54M |
| -Other payable | ---- | ---- | ---- | 49.91%35.27M | ---- | -1.91%26.03M | ---- | 70.14%23.53M | ---- | 61.49%26.54M |
| Non current liabilities due within one year | 46.07%2.74M | ---- | -59.23%1.02M | -37.35%1.56M | -26.90%1.87M | -29.89%1.99M | -80.10%2.51M | -78.05%2.49M | --2.56M | -39.06%2.84M |
| Other current liabilities | -55.72%266.85K | 20.08%691.47K | -23.78%165.63K | -44.58%196.89K | -15.79%602.63K | -3.92%575.87K | -78.08%217.31K | -51.91%355.27K | --715.64K | 174.46%599.34K |
| Total current liabilities | 7.68%188.7M | 55.43%216.78M | 19.79%183.03M | 33.46%212.06M | -6.76%175.24M | -10.60%139.47M | -38.32%152.79M | -32.89%158.89M | --187.94M | -29.27%156.01M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 25.92%11.88M | -0.01%9.77M | 382.41%10.68M | 279.51%9.45M | 120.58%9.44M | 81.41%9.78M | 912.58%2.21M | --2.49M | --4.28M | --5.39M |
| Long term deferred income | 20.25%41.82M | 317.10%41.88M | 242.85%34.65M | 241.31%34.71M | 239.79%34.78M | -2.50%10.04M | -2.48%10.11M | -2.47%10.17M | --10.23M | -2.44%10.3M |
| Lease liabilities | 732.03%4.13M | 209.44%2.25M | ---- | -89.59%138.43K | -77.50%496.43K | -74.75%727.44K | -71.22%687.36K | -54.74%1.33M | --2.21M | --2.88M |
| Total non current liabilities | 29.35%57.83M | 162.41%53.91M | 248.48%45.33M | 216.65%44.3M | 167.42%44.71M | 10.64%20.54M | -72.69%13.01M | -68.94%13.99M | --16.72M | -54.65%18.57M |
| Total liabilities | 12.08%246.53M | 69.16%270.69M | 37.74%228.36M | 48.29%256.36M | 7.47%219.95M | -8.34%160.02M | -43.86%165.79M | -38.65%172.88M | --204.66M | -33.24%174.58M |
| Shareholders equity | ||||||||||
| Paid-in capital | 40.00%280.06M | 40.00%280.06M | 40.00%280.06M | 40.00%280.06M | 50.00%200.04M | 50.00%200.04M | 100.04%200.04M | 100.04%200.04M | --133.36M | 33.36%133.36M |
| Capital reserve funds | -11.04%644.77M | -11.04%644.77M | -11.04%644.77M | -11.04%644.77M | -8.42%724.78M | -8.42%724.78M | 8,665.88%724.78M | 9,773.01%724.78M | --791.46M | 14,325.11%791.46M |
| Surplus reserve funds | 20.94%105.09M | 22.75%99.23M | 23.26%96M | 26.67%92.91M | 30.31%86.89M | 27.14%80.84M | 55.77%77.89M | 46.70%73.35M | --66.68M | 27.17%63.58M |
| Retained profit | 15.65%562.18M | 17.24%511.47M | 15.82%482.88M | 20.39%455.66M | 20.08%486.11M | 20.78%436.25M | 25.66%416.9M | 20.51%378.47M | --404.83M | 48.96%361.2M |
| Specific reserves | 9.28%7.48M | 9.14%6.67M | 31.56%6.72M | 9.94%7.44M | 0.81%6.85M | -3.53%6.11M | -7.90%5.11M | 27.19%6.76M | --6.79M | 38.82%6.33M |
| Shareholders equity without minority interests | 6.31%1.6B | 6.50%1.54B | 6.02%1.51B | 7.04%1.48B | 7.24%1.5B | 6.79%1.45B | 187.48%1.42B | 190.19%1.38B | 220.24%1.4B | 236.85%1.36B |
| Minority interests | -15.17%798.29K | -41.95%854.17K | -30.85%1.54M | -82.78%471.6K | -68.80%941.01K | -54.71%1.47M | -35.21%2.22M | -23.34%2.74M | --3.02M | -15.52%3.25M |
| Total shareholder equity | 6.29%1.6B | 6.45%1.54B | 5.96%1.51B | 6.86%1.48B | 7.07%1.51B | 6.64%1.45B | 185.95%1.43B | 188.60%1.39B | --1.41B | 234.47%1.36B |
| Total liabilityies and equity | 7.03%1.85B | 12.69%1.81B | 9.27%1.74B | 11.46%1.74B | 7.13%1.73B | 4.94%1.61B | 100.51%1.59B | 104.57%1.56B | 113.10%1.61B | 129.64%1.53B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.